Medicare Enrolled

Dr. Donald Rabil, MD

Pulmonary Disease · Durham, NC
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
4101 N ROXBORO ST, Durham, NC 27704
9196848111
In practice since 2005 (20 years)
NPI: 1144214917 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rabil from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rabil? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rabil

Dr. Donald Rabil is a pulmonary disease specialist in Durham, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rabil performed 2,893 Medicare services across 2,500 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rabil received a total of $7,992 from 27 pharmaceutical and/or device companies across 468 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rabil is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 8% volume in NC $7,992 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,893
Medicare services
Top 8% in NC for pulmonary disease
2,500
Unique beneficiaries
$44
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~145 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Airflow rate measurement test
A test that measures the rate of airflow. This procedure assesses how quickly air moves.
1,230 $26 $117
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
463 $38 $199
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
358 $88 $255
Lung volume test using sensors
A test that measures the amount of air in the lungs using sensors.
318 $38 $200
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
110 $124 $344
Lung volume test using gas dilution or washout
A test that measures the amount of air in your lungs by using a gas dilution or washout method.
72 $8 $47
Expiratory airflow and volume test
A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume.
64 $6 $33
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
56 $116 $390
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
39 $10 $79
New patient office visit, complex (60-74 min) 36 $152 $490
Nitric oxide gas level test
A test that measures the level of nitric oxide gas in the body.
35 $12 $60
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
29 $29 $57
Flu vaccine, quadrivalent
A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection.
25 $76 $215
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
21 $66 $174
Lung volume measurement test
A test that measures the largest amount of air you can breathe in and out. It evaluates the total capacity of your lungs.
20 $9 $71
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
17 $142 $486
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,992
Total received (2018-2024)
Avg $1,142/year across 7 years
Top 21% in NC for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
468
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,910 (99.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$83 (1.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$126
2023
$96
2022
$141
2021
$120
2020
$622
2019
$3,893
2018
$2,995

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$65
Boehringer Ingelheim Pharmaceuticals, Inc.
$61
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,909
AstraZeneca Pharmaceuticals LP
$1,172
Genentech USA, Inc.
$841
GlaxoSmithKline, LLC.
$756
Sunovion Pharmaceuticals Inc.
$611
Regeneron Healthcare Solutions, Inc.
$376
Novartis Pharmaceuticals Corporation
$364
Grifols USA, LLC
$268
GENZYME CORPORATION
$236
Philips Electronics North America Corporation
$223
Actelion Pharmaceuticals US, Inc.
$221
Mallinckrodt LLC
$144
Mylan Specialty L.P.
$123
Merck Sharp & Dohme Corporation
$122
Pulmonx Corporation
$116
Teva Pharmaceuticals USA, Inc.
$111
Advanced Respiratory, Inc
$68
PFIZER INC.
$67
Insmed, Inc.
$64
Mallinckrodt Enterprises LLC
$55
Circassia Pharmaceuticals Inc
$43
Breathe Technologies, Inc.
$22
ADVANCED RESPIRATORY, INC
$21
United Therapeutics Corporation
$18
Allergan Inc.
$16
Shire North American Group Inc
$15
Gilead Sciences, Inc.
$14
Top 3 companies account for 49.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ANORO · ANORO ELLIPTA · ASMANEX · AVYCAZ · Arikayce · BREO · BREZTRI · CHANTIX · CINQAIR · COMBIVENT RESPIMAT · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · DreamWear Full · Dymista · Esbriet · FASENRA · GLASSIA · LONHALA MAGNAIR · Life2000 Ventilation System · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Prolastin-C · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · QVAR · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TRELEGY ELLIPTA · TUDORZA PRESSAIR · The Vest System Model 105 Home Care · Trilogy 100 · UTIBRON NEOHALER · Utibron · Wellcentive Undiv · XOLAIR · Xolair · Yupelri · ZERBAXA · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a pulmonary disease specialist in Durham?
Compare pulmonary diseases in the Durham area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
51
Per 100K population
15.5
County median income
$79,501
Nearest hospital
NORTH CAROLINA SPECIALTY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Rabil is a clinical cardiology specialist, with above-average Medicare volume (top 8% in NC), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Rabil experienced with airflow rate measurement test?
Based on Medicare claims data, Dr. Rabil performed 1,230 airflow rate measurement test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rabil receive payments from pharmaceutical companies?
Yes. Dr. Rabil received a total of $7,992 from 27 companies across 468 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rabil's costs compare to other pulmonary diseases in Durham?
Dr. Rabil's average Medicare payment per service is $44. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rabil) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →